• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $OMDA

    Omada Health Inc.

    Subscribe to $OMDA
    $OMDA
    Medical/Nursing Services
    Health Care

    IPO Year: 2025

    Exchange: NASDAQ

    Recent Analyst Ratings for Omada Health Inc.

    DatePrice TargetRatingAnalyst
    7/1/2025$21.00Outperform
    Evercore ISI
    7/1/2025$25.00Overweight
    Morgan Stanley
    7/1/2025$19.00Overweight
    Analyst
    7/1/2025$23.00Buy
    Needham
    7/1/2025$21.00Overweight
    Barclays
    7/1/2025$29.00Buy
    Goldman
    7/1/2025$27.00Buy
    Canaccord Genuity
    See more ratings

    Omada Health Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Evercore ISI initiated coverage on Omada Health with a new price target

      Evercore ISI initiated coverage of Omada Health with a rating of Outperform and set a new price target of $21.00

      7/1/25 8:41:36 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on Omada Health with a new price target

      Morgan Stanley initiated coverage of Omada Health with a rating of Overweight and set a new price target of $25.00

      7/1/25 8:21:32 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Analyst initiated coverage on Omada Health with a new price target

      Analyst initiated coverage of Omada Health with a rating of Overweight and set a new price target of $19.00

      7/1/25 8:21:32 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Barclays initiated coverage on Omada Health with a new price target

      Barclays initiated coverage of Omada Health with a rating of Overweight and set a new price target of $21.00

      7/1/25 8:21:11 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Needham initiated coverage on Omada Health with a new price target

      Needham initiated coverage of Omada Health with a rating of Buy and set a new price target of $23.00

      7/1/25 8:21:11 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Goldman initiated coverage on Omada Health with a new price target

      Goldman initiated coverage of Omada Health with a rating of Buy and set a new price target of $29.00

      7/1/25 8:20:56 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on Omada Health with a new price target

      Canaccord Genuity initiated coverage of Omada Health with a rating of Buy and set a new price target of $27.00

      7/1/25 8:20:35 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care

    Omada Health Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

      SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

      6/17/25 9:00:00 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Smart Healthcare Is Taking Over. Here's Where the Money's Headed

      Issued on behalf of Avant Technologies Inc.Equity Insider News Commentary VANCOUVER, BC, June 10, 2025 /PRNewswire/ -- Both politicians and leaders in academia are touting the AI revolution empowering the frontline of what's dubbed Smart Healthcare. In a recent write-up in Forbes, Prof. Nicos Savva of the London Business School cited recent speeches from former British Prime Minister Tony Blair, who insists that the UK needs to embrace a future with AI doctors and nurses, or risk being left behind. A new report from Wolters Kluwer has experts calling for more clarity around its use, adoption, and business strategy, because most healthcare organizations aren't currently ready to use GenAI too

      6/10/25 11:13:00 AM ET
      $AMZN
      $GOOG
      $GOOGL
      $OMDA
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology

    Omada Health Inc. SEC Filings

    See more
    • SEC Form 8-K filed by Omada Health Inc.

      8-K - Omada Health, Inc. (0001611115) (Filer)

      6/9/25 4:05:24 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • SEC Form 424B4 filed by Omada Health Inc.

      424B4 - Omada Health, Inc. (0001611115) (Filer)

      6/9/25 6:07:31 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care

    Omada Health Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Revelation Alpine, Llc converted options into 4,181,664 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 5:22:16 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Large owner Revelation Alpine, Llc converted options into 4,181,664 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 5:13:11 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Root Jonathan D was granted 9,736 shares and converted options into 4,684,659 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:20:57 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Fetter Trevor was granted 9,736 shares and converted options into 111,200 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:19:15 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Beal Anne was granted 9,736 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:17:29 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Stavisky Adam was granted 9,736 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:15:51 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Klapstein Julie D was granted 9,736 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:15:06 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Jain Sachin H. was granted 9,736 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:14:28 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Hilleman Jeryl L was granted 9,736 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:13:22 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • President Shao Wei-Li was granted 78,947 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:12:30 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care

    Omada Health Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

      SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

      6/17/25 9:00:00 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care